Clinical trials
Shock, Septic trials in Spain
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
30 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2003 | 1 |
| 2004 | 1 |
| 2005 | 1 |
| 2006 | 2 |
| 2008 | 1 |
| 2010 | 1 |
| 2012 | 2 |
| 2013 | 2 |
| 2015 | 1 |
| 2016 | 2 |
| 2017 | 2 |
| 2018 | 5 |
| 2019 | 1 |
| 2020 | 2 |
| 2022 | 2 |
| 2024 | 1 |
| 2025 | 1 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 15 |
| Unknown status | 6 |
| Recruiting | 4 |
| Active, not recruiting | 2 |
| Terminated | 2 |
| Not yet recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Clinica Universidad de Navarra, Universidad de Navarra | 2 |
| Fundación Pública Andaluza para la gestión de la Investigación en Sevilla | 2 |
| Hospital de Granollers | 2 |
| Inotrem | 2 |
| Aragon Institute of Health Sciences | 1 |
| AstraZeneca | 1 |
| Corporacion Parc Tauli | 1 |
| Cristina Martinez | 1 |
| CytoSorbents, Inc | 1 |
| Eisai Inc. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Shock, Septic | 30 |
| Sepsis | 17 |
| Acute Kidney Injury | 3 |
| Shock, Cardiogenic | 3 |
| Respiratory Distress Syndrome | 2 |
| Respiratory Insufficiency | 2 |
| Acute-On-Chronic Liver Failure | 1 |
| Burns | 1 |
| Communicable Diseases | 1 |
| Cytokine Release Syndrome | 1 |
Trials
Showing 26 to 30 of 30. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.